NASDAQ$RNA

Atrium Therapeutics Inc · Q1 2022 earnings

Q1 2022 earnings ·

Headline financials

Total Revenue

$1.8M

Previous: $2.7M-33.6%
Capital Expenditures

-$758K

Previous: -$525K-44.4%
Free Cash Flow

-$35M

Previous: -$24.4M-43.6%
Net Income

-$34.2M

Previous: -$23.8M-43.6%
Operating Income

-$34.5M

Previous: -$23.9M-44.4%
Gross Profit

$0.00

Previous: $0.00

Revenue & EPS history

Atrium Therapeutics Inc · Revenue · Quarterly

$1.8M

Q1 2022-33.6%vs Q1 2021
Beat estimate in 1 of 1 quarters(100%)
ActualEstimate

Revenue by segment

Atrium Therapeutics Inc · $19.6M total across 1 segment · Q1 2026

  • Reportable Segment
    $19.6M—

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro